Dr Reddys Laboratories annual ebitda margin
2018
2019
2020
2021
2022
2023
2024
2025
Dr Reddys Laboratories EBITDA Margin Growth & History (RDY)
Dr Reddys Laboratories's ebitda margin was 27.34% for fiscal 2025.
View full Dr Reddys Laboratories company overviewDr Reddys Laboratories annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-03-31 | 27.34% | −2.24 pp |
| 2024 | 2024-03-31 | 29.58% | +1.21 pp |
| 2023 | 2023-03-31 | 28.38% | +9.09 pp |
| 2022 | 2022-03-31 | 19.29% | −0.26 pp |
| 2021 | 2021-03-31 | 19.55% | +3.27 pp |
| 2020 | 2020-03-31 | 16.28% | −5.21 pp |
| 2019 | 2019-03-31 | 21.48% | +4.84 pp |
| 2018 | 2018-03-31 | 16.64% | — |
Dr Reddys Laboratories ebitda margin trends
Over the last five fiscal years, Dr Reddys Laboratories's ebitda margin increased from 16.28% to 27.34%, a change of +11.06 percentage points.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dr Reddys Laboratories source filings ↗